Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 29 June 2009, doi:10.1136/bmj.b2600
Cite this as: BMJ 2009;338:b2600
| The first 150 words of the full text of this article appear below. |
Law and colleagues conclusion, that blood pressure should be lowered in everyone over a certain age, rather than measured in everyone and treated in some, is derived from 147 disparate trials.1 The trials have varying inclusion/exclusion criteria, and were conducted in patients aged 34-84, with follow-up of 0.5-8.4 years, and in those with hypertension, after myocardial infarction, with coronary artery disease without myocardial infarction, and with heart failure. Treatment was with various agents at varying doses and frequency and effect on blood pressure, with differing definitions of end point, but they still result in one simple conclusion—blood pressure measurement is useless.
Whereas figure 2 seems to show that antihypertensive agents are efficacious at a wide range of blood pressures (110->170/70->95 mm Hg), the higher blood pressures (>140 mm Hg) were in hypertension trials and the lower values in heart failure.2 3 Extrapolating these results to healthy people with systolic pressures of
Sripal Bangalore1, Franz H Messerli2
1 Division of Cardiology, Brigham and Womens Hospital and Harvard Medical School, Boston, MA 02445, USA, 2 St Lukes Roosevelt Hospital and Columbia University College of Physicians and Surgeons, New York, NY, USA
sbangalore@partners.org